News
(Reuters) -Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 ...
Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) ...
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.
Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...
This vaccine did previously have emergency approval by the FDA for use but can now be marketed in the U.S. for use, the ...
Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...
The head of the Food and Drug Administration said the agency will soon unveil a new framework detailing what companies must ...
A top agency official is meeting with industry and FDA staff as he works on guidance clarifying the FDA’s expectations for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results